Press release
Global Market Study On Dystrophin (DMD) - Pipeline Review, H2 2017 | MarketResearchReports.biz
According to the recently published report 'Dystrophin (DMD) - Pipeline Review, H2 2017'; Dystrophin (DMD) pipeline Target constitutes close to 27 molecules. Out of which approximately 23 molecules are developed by companies and remaining by the universities/institutes.
Dystrophin (DMD) - Dystrophin is a cytoplasmic protein. It anchors the extracellular matrix to the cytoskeleton via F-actin. It acts as ligand for dystroglycan. It act as component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction and at a variety of synapses in the peripheral and central nervous systems and has a structural function in stabilizing the sarcolemma.
The report 'Dystrophin (DMD) - Pipeline Review, H2 2017' outlays comprehensive information on the Dystrophin (DMD) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type; that are being developed by Companies / Universities.
View Report @ https://www.marketresearchreports.biz/reports/1473412/dystrophin-dmd-pipeline-review-h2-2017-market-research-reports
It also reviews key players involved in Dystrophin (DMD) targeted therapeutics development with respective active and dormant or discontinued projects. Currently, The molecules developed by companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 2, 3, 2, 5 and 10 respectively. Similarly, the universities portfolio in Phase I and Preclinical stages comprises 1 and 3 molecules, respectively. Report covers products from therapy areas Genetic Disorders and Musculoskeletal Disorders which include indications Duchenne Muscular Dystrophy and Muscular Dystrophy.
Scope
- The report provides a snapshot of the global therapeutic landscape for Dystrophin (DMD)
- The report reviews Dystrophin (DMD) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Dystrophin (DMD) targeted therapeutics and enlists all their major and minor projects
- The report assesses Dystrophin (DMD) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to Dystrophin (DMD) targeted therapeutics
Get Sample Copy Of This Report @
https://www.marketresearchreports.biz/sample/sample/1473412
Reasons to buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for Dystrophin (DMD)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Dystrophin (DMD) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Send An Enquiry Request @
https://www.marketresearchreports.biz/sample/enquiry/1473412
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Dystrophin (DMD) - Overview
Dystrophin (DMD) - Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies
Products under Development by Universities/Institutes
Dystrophin (DMD) - Therapeutics Assessment
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Dystrophin (DMD) - Companies Involved in Therapeutics Development
BioMarin Pharmaceutical Inc
Daiichi Sankyo Co Ltd
Editas Medicine Inc
Genethon SA
NS Pharma Inc
Pfizer Inc
Sarepta Therapeutics Inc
WAVE Life Sciences Ltd
Dystrophin (DMD) - Drug Profiles
Antisense Oligonucleotide 1 to Activate Dystrophin for Duchenne Muscular Dystrophy - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Antisense Oligonucleotide to Activate Dystrophin for Duchenne Muscular Dystrophy - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
About Us:
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact
Mr. Nachiketa
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Market Study On Dystrophin (DMD) - Pipeline Review, H2 2017 | MarketResearchReports.biz here
News-ID: 889994 • Views: …
More Releases from MarketResearchReports.biz
Hydro-flyers Market: Moving Towards a Brighter Future
A hydro-flyer is an adventure sporting device which uses the propulsion of water jet technology to create continuous flight movement, where the lift and movement are controlled by the flyer. Hydro-flyers sporting devices make use of the flow of water power to drive the flyer to reach soaring heights. The rise in water sporting facilities is one of the major factors that promote the growth and demand for hydro-flyers in…
Outdoor Floodlights: Technology and Market Dynamics
Outdoor floodlights is a reliable, highly efficient, and economical solution for a wide range of outdoor applications. These lights are resistant to temperature fluctuations and they remain stable even in extreme climatic conditions. Unlike the traditional lights, floodlights remain stable and functional even in harsh climatic conditions. This makes them ideal for use in any climate and any outdoor application. Outdoor floodlights save a significant amount of energy and consume…
Snow Helmets Market Future Prospects and Regional Outlook
Riders are riding faster and getting bolder day by day. Hence, safety equipment need to be updated as per the requirement and changing time. Earlier, helmets were primarily used by extreme skiers and racers. They were used only on slopes. However, later, the use of helmets was made compulsory. Earlier, bulky black helmets were used by riders, which are outdated at present. Currently, new stylish helmets that can match with…
Predictions for 2019: Global Sparkling Water Dispensers Industry Is Set to Boom
Sparkling water dispensers are equipment used for dispensing carbonated water. These dispensers mix the still, filtered water with carbon dioxide before dispensing. Sparkling water dispensers are mostly used in households and commercial establishments such as amusement parks, hotels, restaurants, and sports arenas. A sparkling water dispenser has separate outlets for hot water and cold water. The hot water outlet does not require a separate filtration process. However, cold water is…
More Releases for Dystrophin
Investors who lost money with shares of PepGen Inc. (NASDAQ: PEPG) should contac …
An investor, who purchased shares of PepGen Inc. (NASDAQ: PEPG), filed a lawsuit over alleged violations of Federal Securities Laws by PepGen Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of PepGen Inc. (NASDAQ: PEPG) have certain options and for certain investors are short and strict deadlines running. Deadline: August 8, 2025. NASDAQ: PEPG investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Dystrophin Gene Therapy Market - Dystrophin Clinical Trials To Reach US$ 6.98 Bi …
The Dystrophin Gene Therapy Market reached US$ 1.20 billion in 2023 and is expected to reach US$ 6.98 billion by 2031, growing at a CAGR of 22.9% during the forecast period 2024-2031.
The Dystrophin Gene Therapy Market report, released by DataM Intelligence, offers comprehensive insights and thorough analysis of major market trends, growth prospects, and emerging challenges. With a strong focus on actionable intelligence, DataM Intelligence equips businesses with the knowledge…
Duchenne Muscular Dystrophy (DMD) Pipeline Analysis, 2024 | Insights into Recent …
Duchenne Muscular Dystrophy Clinical Trial Updates 2024 | FDA Approvals and Focused Therapies: Vyondys 53 (Golodirsen), Emflaza, Exondys 51, Translarna, Amondys 45, Viltepso, PF-06939926, and Vamorolone.
According to DelveInsight's analysis, over 75 key pharmaceutical and biotech companies are currently developing more than 75 pipeline drugs in the Duchenne Muscular Dystrophy (DMD) therapeutics landscape. These drugs vary in terms of Routes of Administration (RoA), Mechanism of Action (MoA), and molecule types. Many…
Dystrophin Market Poised for Significant Growth: A Promise for Muscular Dystroph …
The dystrophin market is experiencing a surge of interest due to its potential to revolutionize the treatment of muscular dystrophy (MD), a debilitating genetic disorder. This press release delves into the current landscape of the dystrophin market, exploring key trends, drivers, and opportunities that will shape its future trajectory.
Get Free Exclusive Sample PDF Copy: @ https://www.reportsanddata.com/download-free-sample/1063
Market Overview and Trends
The global dystrophin market is projected to reach a staggering USD 28.20…
Dystrophin Market Expansion Prospects 2023-2030 Growth Roadmap | Asklepios BioPh …
Infinity Business Insights: Statistical Analysis report on "Dystrophin Market" capacity, production, production value, cost/profit, supply/demand and import/export. The report will assist reader with better understanding and decision making.
The Dystrophin Market is a segment of the global pharmaceutical and biotechnology industry that focuses on developing and providing treatments for Duchenne muscular dystrophy (DMD) and related disorders. DMD is a rare and debilitating genetic disorder that primarily affects young boys, leading to…
DystrophinMarket is set to Fly High Growth in Years to Come (2022-2028).
Stats and Research is excited to announce the release of its latest research report on the Global Dystrophin Market. This report provides a comprehensive overview of the market and its key players, with a focus on their products, applications, and specifications. It also features a thorough analysis of the market, including market trends, growth factors, and opportunities for growth.
Market Overview:
The Dystrophin market has experienced significant growth in recent years and…
